Skip to main content
. 2018 Nov 23;9(92):36515–36529. doi: 10.18632/oncotarget.26369

Figure 2. Glo1 is overexpressed in basal-like breast cancers.

Figure 2

(A) Paired comparison of Glo1 expression in normal tissue and tumor tissue from each subtypes using TCGA dataset (Wilcoxon signed rank test: Luminal A, n = 32 in each group; Luminal B, n = 13 in each group; HER2-enriched, n = 4 in each group; Basal-like, n = 11 in each group) (from the METABRIC dataset). (B) Glo1 expression in breast cancer subtypes: centerline, median; box limits, upper and lower quartiles; whiskers, ± 1.5 × interquartile range (IQR); points, all data points. **p < 0.01; Kruskal-Wallis test with Steel-Dwass test. (C) Proportions (%) of tumor grades in each subtype (from the METABRIC dataset).